XENE Xenon Pharmaceuticals Inc.

NASDAQ
$37.68

Xenon Pharmaceuticals Inc. (XENE) Earnings News

Earnings press releases, previews and reviews for Xenon Pharmaceuticals Inc. (XENE), newest first. Our most recent is preview: Xenon's NDA Filing Status Takes Center Stage After a 40% Slide Despite Upbeat Guidance.